"March Against Monsanto" protesters say they want to call attention to the dangers posed by genetically modified food.
05/25/13 - 06:29 PM EDT
Biotech columnist Adam Feuerstein answers readers' questions about health-care companies.
05/24/13 - 07:00 AM EDT
One trader believes Rockwell shares will rise into clinical trial results expected in July.
05/21/13 - 08:00 AM EDT
Two charts show how investors feel differently about Keryx and Acadia Pharma.
05/21/13 - 10:38 AM EDT
Actavis took the offensive in plans to acquire specialty pharmaceuticals firm Warner Chilcott plc for $8.5 billion in stock and assumed debt.
05/20/13 - 10:01 AM EDT
Another entrepreneurial U.S. startup bites the dust... sort of.
05/20/13 - 02:27 PM EDT
TheStreet senior columnist Adam Feuerstein discusses the winners and losers from the research abstracts ahead of the ASCO cancer conference.
05/16/13 - 02:09 PM EDT
Dan Loeb gets soft, Bloomberg and traders are 'Spy vs. Spy,' and Wal-Mart torpedos a cooperative reform effort by choosing its own, awkward path.
05/17/13 - 07:00 AM EDT
Get a head start on searching through ASCO abstracts with these 10 summaries.
05/15/13 - 06:00 PM EDT
At some point, investors will give Aveo credit for tivozanib, says David Sobek.
05/15/13 - 09:24 AM EDT
The market overreacted to the resignation of Synta's R&D chief.
05/14/13 - 10:16 AM EDT
The stock has the highest forward P/E among components of the KBW Bank Index, justified by strong long-term earnings and growth prospects.
05/14/13 - 10:23 AM EDT